Effect of palonosetron (5HT-3 antagonist) and pantoprazole (proton pump inhibitor) against surgical esophagitis induced by forestomach and pylorus ligation in albino rats

Human & Experimental Toxicology
A KumarGaurav Kaithwas

Abstract

This study was embarked upon to evaluate the effects of pantoprazole and palonosetron on experimental esophagitis in albino wistar rats. Groups of rats, fasted for 36 h, were subjected to pylorus and forestomach ligation, supervened by treatment with normal saline (3 ml/kg, po, sham control), esophagitis control (3 ml/kg, po), pantoprazole (30 mg/kg, po), palonosetron (0.5 mg/kg, po), and their combination. Animals were sacrificed after 12 h and appraised for the volume of gastric juices, total acidity, free acidity, and esophagitis index. Esophageal tissues were further figured out biochemically for markers of oxidative stress and inflammatory mediators. The combination therapy comparably inhibited the esophagitis index (52.86%), gastric volume (66.04%), free acidity (43.76%), and total acidity (42.60%) in comparison with toxic control. The combination therapy also subsidized the biochemical and inflammatory markers to the purview less than toxic control. The morphological changes were scrutinized by scanning electron microscopy and were observed to demonstrate momentous protection by the amalgamation therapy. Combination therapy with pantoprazole and palonosetron flaunted sententious protection against experimental esophagitis.

References

Jun 1, 1979·Analytical Biochemistry·H OhkawaK Yagi
Jan 1, 1994·Methods in Enzymology·A Z Reznick, L Packer
Aug 15, 1997·The Journal of Biological Chemistry·B S Berlett, E R Stadtman
May 2, 2001·Digestive Diseases and Sciences·R J WhiteW G Paterson
May 30, 2003·Pharmacological Reviews·K AsadullahH D Volk
May 1, 1959·Archives of Biochemistry and Biophysics·G L ELLMAN
May 11, 2005·World Journal of Gastroenterology : WJG·Pilar JiménezAngel Lanas
Oct 15, 2005·Surgical Innovation·Yesim ErbilBayindir Cimşit
Mar 15, 2006·Digestive Diseases and Sciences·Kenji NagahamaKoji Takeuchi
Mar 19, 2008·Journal of Ethnopharmacology·Gurvinder SinghAnand C Burman
Oct 9, 2008·Current Opinion in Pharmacology·Carmelo Scarpignato, Richard H Hunt
Nov 14, 2008·Current Gastroenterology Reports·Jai Moo Shin, George Sachs
Mar 31, 2011·World Journal of Gastroenterology : WJG·Fabio PaceUNKNOWN EMERGE Study Group
Jan 6, 2012·The American Journal of Gastroenterology·Albert J Bredenoord
Sep 13, 2013·BioMed Research International·Ekta AryaGaurav Kaithwas
Dec 21, 2013·The Journal of Biological Chemistry·Robert van der BurghMarianne Boes

❮ Previous
Next ❯

Methods Mentioned

BETA
dissection
MDA

Software Mentioned

GraphPad Prism

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Atrophic Gastritis

Atrophic Gastritis is a process where gastric glandular cells are lost and replaced with firbous tissues, as a result of chronic inflammation. Learn more about Atrophic Gastritis here.

Barrett Esophagus

Barrett’s esophagus if a serious complication of gastroesophageal reflux disease during which the normal esophageal lining changes to tissue that resembles intestinal lining. Here is the latest research.

Related Papers

BMC Complementary and Alternative Medicine
Arvind Kumar GiriGaurav Kaithwas
Pharmacological Research : the Official Journal of the Italian Pharmacological Society
S K SrivastavaG P Gupta
© 2022 Meta ULC. All rights reserved